Your browser doesn't support javascript.
loading
Human liver microbiota modeling strategy at the early onset of fibrosis.
Champion, Camille; Neagoe, Radu M; Effernberger, Maria; Sala, Daniela T; Servant, Florence; Christensen, Jeffrey E; Arnoriaga-Rodriguez, Maria; Amar, Jacques; Lelouvier, Benjamin; Loubieres, Pascale; Azalbert, Vincent; Minty, Matthieu; Thomas, Charlotte; Blasco-Baque, Vincent; Gamboa, Fabrice; Tilg, Herbert; Cardellini, Marina; Federici, Massimo; Fernández-Real, Jose-Manuel; Loubes, Jean Michel; Burcelin, Rémy.
Affiliation
  • Champion C; Institut National de La Santé Et de La Recherche Médicale (INSERM), Toulouse, France.
  • Neagoe RM; Unité Mixte de Recherche (UMR) 1297, Institut Des Maladies Métaboliques Et Cardiovasculaires (I2MC), Team 2: 'Intestinal Risk FactorsDiabetesDyslipidemia', Université Paul Sabatier (UPS), F-31432, Toulouse Cedex 4, France.
  • Effernberger M; Institut de Mathématiques de Toulouse, Université Paul Sabatier, Toulouse, France.
  • Sala DT; Second Department of Surgery, Emergency Mures County Hospital, University of Medicine Pharmacy, Science and Technology "George Emil Palade" Tîrgu Mures, Târgu Mureș, Romania. neagoerm@gmail.com.
  • Servant F; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Innsbruck, Austria.
  • Christensen JE; Second Department of Surgery, Emergency Mures County Hospital, University of Medicine Pharmacy, Science and Technology "George Emil Palade" Tîrgu Mures, Târgu Mureș, Romania.
  • Arnoriaga-Rodriguez M; VAIOMER, 516 Rue Pierre Et Marie Curie, 31670, Labège, France.
  • Amar J; Institut National de La Santé Et de La Recherche Médicale (INSERM), Toulouse, France.
  • Lelouvier B; Unité Mixte de Recherche (UMR) 1297, Institut Des Maladies Métaboliques Et Cardiovasculaires (I2MC), Team 2: 'Intestinal Risk FactorsDiabetesDyslipidemia', Université Paul Sabatier (UPS), F-31432, Toulouse Cedex 4, France.
  • Loubieres P; Department of Diabetes, Endocrinology and Nutrition, University Hospital of Girona 'Dr Josep Trueta', Girona, Spain.
  • Azalbert V; Institut d'Investigacio Biomedica de Girona IdibGi, Girona, Spain.
  • Minty M; CIBER Fisiopatologia de La Obesidad Y Nutricion, Girona, Spain.
  • Thomas C; Institut National de La Santé Et de La Recherche Médicale (INSERM), Toulouse, France.
  • Blasco-Baque V; Unité Mixte de Recherche (UMR) 1297, Institut Des Maladies Métaboliques Et Cardiovasculaires (I2MC), Team 2: 'Intestinal Risk FactorsDiabetesDyslipidemia', Université Paul Sabatier (UPS), F-31432, Toulouse Cedex 4, France.
  • Gamboa F; Therapeutics Department, Rangueil Hospital, Toulouse, France.
  • Tilg H; VAIOMER, 516 Rue Pierre Et Marie Curie, 31670, Labège, France.
  • Cardellini M; Institut National de La Santé Et de La Recherche Médicale (INSERM), Toulouse, France.
  • Federici M; Unité Mixte de Recherche (UMR) 1297, Institut Des Maladies Métaboliques Et Cardiovasculaires (I2MC), Team 2: 'Intestinal Risk FactorsDiabetesDyslipidemia', Université Paul Sabatier (UPS), F-31432, Toulouse Cedex 4, France.
  • Fernández-Real JM; Institut National de La Santé Et de La Recherche Médicale (INSERM), Toulouse, France.
  • Loubes JM; Unité Mixte de Recherche (UMR) 1297, Institut Des Maladies Métaboliques Et Cardiovasculaires (I2MC), Team 2: 'Intestinal Risk FactorsDiabetesDyslipidemia', Université Paul Sabatier (UPS), F-31432, Toulouse Cedex 4, France.
  • Burcelin R; Institut National de La Santé Et de La Recherche Médicale (INSERM), Toulouse, France.
BMC Microbiol ; 23(1): 34, 2023 01 30.
Article in En | MEDLINE | ID: mdl-36717776
ABSTRACT

BACKGROUND:

Gut microbiota is involved in the development of liver diseases such as fibrosis. We and others identified that selected sets of gut bacterial DNA and bacteria translocate to tissues, notably the liver, to establish a non-infectious tissue microbiota composed of microbial DNA and a low frequency live bacteria. However, the precise set of bacterial DNA, and thereby the corresponding taxa associated with the early stages of fibrosis need to be identified. Furthermore, to overcome the impact of different group size and patient origins we adapted innovative statistical approaches. Liver samples with low liver fibrosis scores (F0, F1, F2), to study the early stages of the disease, were collected from Romania(n = 36), Austria(n = 10), Italy(n = 19), and Spain(n = 17). The 16S rRNA gene was sequenced. We considered the frequency, sparsity, unbalanced sample size between cohorts to identify taxonomic profiles and statistical differences.

RESULTS:

Multivariate analyses, including adapted spectral clustering with L1-penalty fair-discriminant strategies, and predicted metagenomics were used to identify that 50% of liver taxa associated with the early stage fibrosis were Enterobacteriaceae, Pseudomonadaceae, Xanthobacteriaceae and Burkholderiaceae. The Flavobacteriaceae and Xanthobacteriaceae discriminated between F0 and F1. Predicted metagenomics analysis identified that the preQ0 biosynthesis and the potential pathways involving glucoryranose and glycogen degradation were negatively associated with liver fibrosis F1-F2 vs F0.

CONCLUSIONS:

Without demonstrating causality, our results suggest first a role of bacterial translocation to the liver in the progression of fibrosis, notably at the earliest stages. Second, our statistical approach can identify microbial signatures and overcome issues regarding sample size differences, the impact of environment, and sets of analyses. TRIAL REGISTRATION TirguMECCH ROLIVER Prospective Cohort for the Identification of Liver Microbiota, registration 4065/2014. Registered 01 01 2014.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Microbiota / Liver Cirrhosis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Microbiol Journal subject: MICROBIOLOGIA Year: 2023 Document type: Article Affiliation country: France Publication country: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Microbiota / Liver Cirrhosis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Microbiol Journal subject: MICROBIOLOGIA Year: 2023 Document type: Article Affiliation country: France Publication country: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM